Evidence map›Paper›PMID 35699436›Full record

ArticleJournal of clinical microbiology2022

Validation of Fourier Transform Infrared Spectroscopy for Serotyping of Streptococcus pneumoniae.

I Passaris, N Mauder, M Kostrzewa, I Burckhardt, S Zimmermann, N M van Sorge, H-C Slotved, S Desmet, P-J Ceyssens

Open access · hybridAbstract read
In one paragraph

Article in Journal of clinical microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 25 citations in OpenAlex.

  1. A standardized workflow for typing S. marcescens outbreaks using FT-IR spectroscopy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Fourier-transform infrared spectroscopy for rapidFrontiers in microbiology · 2025
    Article
  11. Non-invasiveEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Fourier transform infrared spectroscopy forFrontiers in microbiology · 2024
    Article
  17. What are the most relevant publications in Clinical Microbiology in the last two years?Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

I PassarisBacterial Diseases Unit, Sciensano, Brussels, Belgium.ORCID 0000-0003-1649-2153
N MauderBruker Daltonic GmbH, Bremen, Germany.
M KostrzewaBruker Daltonic GmbH, Bremen, Germany.
I BurckhardtDepartment of Infectious Diseases, Microbiology and Hygiene, University Hospital of Heidelberg, Heidelberg, Germany.
S ZimmermannDepartment of Infectious Diseases, Microbiology and Hygiene, University Hospital of Heidelberg, Heidelberg, Germany.ORCID 0000-0001-5601-7934
N M van SorgeDepartment of Medical Microbiology and Infection Prevention, UMC Amsterdam, University of Amsterdam, Amsterdam, The Netherlands.
H-C SlotvedDepartment of Bacteria, Parasites and Fungi, Statens Serum Institutgrid.6203.7, Copenhagen, Denmark.
S DesmetNational Reference Centre for (invasive) S. pneumoniae, UZ Leuven, Leuven, Belgium.ORCID 0000-0002-4338-1929
P-J CeyssensBacterial Diseases Unit, Sciensano, Brussels, Belgium.
Bruker (Germany) · DEHeidelberg University · DESciensano (Belgium) · BEStatens Serum Institut · DKUniversitair Ziekenhuis Leuven · BEUniversity of Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fourier transform infrared (FT-IR) spectroscopy (IR Biotyper; Bruker) allows highly discriminatory fingerprinting of closely related bacterial strains. In this study, FT-IR spectroscopy-based capsular typing of Streptococcus pneumoniae was validated as a rapid, cost-effective, and medium-throughput alternative to the classical phenotypic techniques. A training set of 233 strains was defined, comprising 34 different serotypes and including all 24 vaccine types (VTs) and 10 non-vaccine types (NVTs). The acquired spectra were used to (i) create a dendrogram where strains clustered together according to their serotypes and (ii) train an artificial neural network (ANN) model to predict unknown pneumococcal serotypes. During validation using 153 additional strains, we reached 98.0% accuracy for determining serotypes represented in the training set. Next, the performance of the IR Biotyper was assessed using 124 strains representing 59 non-training set serotypes. In this setting, 42 of 59 serotypes (71.1%) could be accurately categorized as being non-training set serotypes. Furthermore, it was observed that comparability of spectra was affected by the source of the Columbia medium used to grow the pneumococci and that this complicated the robustness and standardization potential of FT-IR spectroscopy. A rigorous laboratory workflow in combination with specific ANN models that account for environmental noise parameters can be applied to overcome this issue in the near future. The IR Biotyper has the potential to be used as a fast, cost-effective, and accurate phenotypic serotyping tool for S. pneumoniae.

Indexed as

Pneumococcal InfectionsStreptococcus pneumoniaeBacteriaHumansSerogroupSerotypingSpectroscopy, Fourier Transform InfraredFT-IR spectroscopymachine learningpneumococcusserotypingStreptococcus pneumoniae

Identifiers

PMID35699436
PMCPMC9297836
OpenAlexW4282920437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.